Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Piper Sandler upgraded MYGN to "overweight" from "neutral" Medical equipment stock Myriad Genetics Inc (NASDAQ:MYGN) was last seen up 9.8% at $11.25, after an upgrade from Piper Sandler to ...